期刊文献+

Notch1在前列腺癌中的表达及临床意义 被引量:1

The expression of Notch1 in prostate cancer tissues and its clinical significance
下载PDF
导出
摘要 目的:研究Notch1在前列腺癌中的表达及临床意义。方法:免疫组化法研究Notch1在前列腺良性增生性病变组织与前列腺癌组织中的表达,分析Notch1表达与肿瘤Gleason评分之间的关系。结果:Notch1在前列腺癌细胞高表达,其表达趋势与前列腺癌的Gleason评分水平呈正相关。结论:Notch1蛋白异常表达可能在前列腺癌的生长、浸润和转移过程中起促进作用,可能成为一种反映前列腺癌生物侵袭性的标志物。 Objective:To determine the expression of Notchl in prostate cancer tissues and to estimate its clinical significance. Methods: Immunohistochemistry was performed to detect Notchl expression in malignant tumor of prostate and benign neoplasia. Results: Notchl was expressed with a much higher level in prostate cancer tissues with comparison to that in the benign neoplasia. And its expression trend was correlated with the malignant degree of the carcinoma. Conclusion: The abnormal expression of Notch1 could play a very important role in promoting the proliferation,invasion and metastasis of prostate cancer,and Notchl could be a marker to reflect the invasion ability of prostate cancer.
出处 《现代肿瘤医学》 CAS 2013年第5期1092-1094,共3页 Journal of Modern Oncology
关键词 前列腺癌 免疫组织化学法 NOTCH1 prostate cancer immunohistochemistry Notchl
  • 相关文献

参考文献12

  • 1Lai EC. Notch signaling : control of cell communication and cell fate[J]. De - velopment ,2004,131:965 - 973.
  • 2Lai EC. Notch signaling : control of cell communication and cell fate[J]. De - velopment ,2004,131:965 - 973.
  • 3张灵,计国义,李晓萌,李胜文,高洪文,甘卉,王洪亮,潘玉琢,孔祥波,桑原正明,赵雪俭.前列腺癌集团检诊对临床前列腺癌诊断的影响[J].中华泌尿外科杂志,2004,25(2):103-105. 被引量:41
  • 4朱刚,刘明,万奔.早期前列腺癌的诊断与治疗[J].中华男科学杂志,2005,11(9):693-696. 被引量:31
  • 5Shou J, Ross S, Koeppen H, et al. Dynamics of notch expressionduring murine prostate development and tumorigenesis [ J]. Canc-er Res,2001,61(10) :7291 -7297.
  • 6Wang XD,Leow CC,Zha JP,et al. Notch signaling is required fornormal prostatic epithelial cell proliferation and differentiation [ J].Dev Biol,2006,290(l) :66 -80.
  • 7Wang XD,Shou J,Wong P,et al. Notchl - expressing cells are in-dis - pensable for prostatic branching morphogenesis during devel-opment and regrowth following castration and androgen replacement[J]. J Biol Chem,2004,279(23) :24733 -24744.
  • 8Zayzafoon M,Abddulkadir SA,Mcdonald JM,et al. Notch sig - nal-ing and ERK activation are important for the osteomimetic proper-ties of prostate cancer bone metastatic cellines lines [ J]. J BiolChem,2004,279(5) :3662 -3670.
  • 9Srivastava S,Ramdass B,Nagar - an S,et al. Notchl regulates thefunctional contribution of RhoC to cervical carcinoma progression[J]. Br J Cancer,2010,102( 1) : 196 -205.
  • 10Zardawi SJ,Zardawi I,McNeil CM,et al. High Notchl protein ex-pression is an early event in breast cancer development and is asso-ciated with the HER - 2 molecular subtype [ J]. Histopathology,2010,56(3):286 -296.

二级参考文献25

  • 1Kaplan ID, Cox RS, Bagshaw MA. Prostate specific antigen after external beam radiotherapy for prostatic cancer: followup[J]. J Urol, 1993, 149(3):519-522.
  • 2Oefelein MG, Smith N, Carter M, et al. The incidence of prostate cancer progression with undetectable serum prostate specific antigen in a series of 394 radical prostatectomies[J]. J Urol, 1995, 154(6):2128-2131.
  • 3Schild SE, Wong WW, Novicki DE, et al. Detection of residual prostate cancer after radical prostatectomy with the Abbott IMx PSA assay[J]. Urology, 1996, 47(6):878-881.
  • 4Crook JM, Bahadur YA, Bociek RG, et al. Radiotherapy for localized prostate carcinoma. The correlation of pretreatment prostate specific antigen and nadir prostate specific antigen with outcome as assessed by systematic biopsy and serum prostate specific antigen[J]. Cancer, 1997, 79(2):328-336.
  • 5American Society for Therapeutic Radiology and Oncology Consensus Panel. Consensus statement: guidelines for PSA following radiation therapy[J]. Int J Radiat Oncol Biol Phys, 1997,37(3):1035-1041.
  • 6Cooperberg MR, Broering JM, Litwin MS, et al. CaPSURE Investigators. The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry[J]. J Urol, 2004, 171(4):1393-1401.
  • 7American cancer society. Cancer facts and figures 2003[M]. Atlanta, GA: American Cancer Society.2001.48-51.
  • 8Parkin DM, Muir CS, Whelan SL. Cancer incidence in five continents [M]. Vol 6. IARC Scientific Pub. No 120. Lyon, France: International Agency of Research on Cancer. 1992.76-79.
  • 9Jemal A, Thomas A, Murray T, et al. Cancer statistics, 2002[J]. CA Cancer J Clin, 2002, 52(1):23-47.
  • 10Thompson IM, Ernst JJ, Gangai MP, et al. Adenocarcinoma of the prostate: results of routine urological screening[J]. J Urol, 1984, 132(4):690-692.

共引文献69

同被引文献4

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部